Lv7
3980 积分 2022-04-05 加入
The latest updates on the proper use of fluoroquinolones – Actualisation 2025 update by the SPILF and the GPIP
2天前
已关闭
The development and benefits of metformin in various diseases
3天前
已完结
Evidentiary Landscape of Heart Failure Therapies, Regulatory Decisions, and Translation Into Guidelines
6天前
已完结
Clinical Pattern of Tolvaptan-Associated Liver Injury in Subjects with Autosomal Dominant Polycystic Kidney Disease: Analysis of Clinical Trials Database
25天前
已完结
Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease
25天前
已完结
Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
25天前
已完结
Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
25天前
已完结
The Effect of Tolvaptan on BP in Polycystic Kidney Disease: A Post Hoc Analysis of the TEMPO 3:4 Trial
25天前
已完结
KDIGO 2025 Clinical Practice Guideline for the Evaluation, Management, and Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
1个月前
已完结
皖公网安备34019202002308
